Sex Differences in the Relation between Comorbidities and Prognosis in Hospitalized Patients with COVID-19

Table 3

Death rate according to the type of comorbidities and sex in hospitalized patients with positive real-time reverse-transcription polymerase chain reaction test results for COVID-19.

	Total, n (%)	Women, n (%)	Men, n (%)	value^1
N (%)	658 (15.1)	289 (14.5)	369 (15.6)	—
DM	155 (20.4)	77 (18.8)	78 (22.2)	0.255
CHD	150 (22.2)	72 (21.1)	78 (23.4)	0.484
Hypertension	123 (17.2)	65 (16.6)	58 (17.8)	0.680
CRD	72 (26.1)	38 (27.1)	34 (25.0)	0.685
Cancer	39 (33.6)	17 (31.5)	22 (35.5)	0.649
CKD	39 (24.8)	15 (22.7)	24 (26.4)	0.602

CHD, coronary heart disease; DM, diabetes mellitus; CRD, chronic respiratory disease; CKD, chronic kidney disease. ^$About 5% of COVID-19 patients have been hospitalized by the time of study (men: 5.6%; women: 4.6%). value comparing death rate in men and women.